Artículos del autor

Dr. Andrés Rodríguez

Member of the Editorial Board of solaci.org
Coronary disease

Coronary Events Following TAVI: A Registry

Between 30 and 70% of patients undergoing transcatheter aortic valve replacement (TAVR) present coronary artery disease (CAD)....
Dr. Andrés Rodríguez -
Structural heart disease

NAVULTRA Registry: One-Year Outcomes of Self-Expanding vs. Balloon-Expandable Valves

In recent years, technological advances and increased operator experience have significantly contributed to improve transcatheter aortic valve...
Dr. Andrés Rodríguez -
Acute coronary syndromes

PROSPECT II Substudy: Relationship Between Different Levels of hs-CRP and Vulnerable Plaque Characteristics in Patients with NSTEMI

Inflammation plays a key role in the onset and progression of atherosclerosis and has been linked to...
Dr. Andrés Rodríguez -
Acute coronary syndromes

Aspirin vs. Clopidogrel Monotherapy After 1 Month of ACS: Subgroup Analysis Based on Bleeding Risk and MI Type

Current guidelines still recommend dual antiplatelet therapy (DAPT) for 12 months following percutaneous coronary intervention (PCI) as...
Dr. Andrés Rodríguez -
Other

Transcatheter Tricuspid Valve Replacement: 1-Year Outcomes

Tricuspid regurgitation (TR) has been associated with increased mortality and functional deterioration. Even though the current guidelines...
Dr. Andrés Rodríguez -
Acute coronary syndromes

EuroPCR 2025 | DANAMI-3-DEFER: 10-Year Results of Deferred vs. Conventional Stenting in STEMI Patients

Primary percutaneous coronary intervention (PCI) with stent implantation is the recommended treatment for ST-segment elevation myocardial infarction...
Dr. Andrés Rodríguez -
Acute coronary syndromes

EuroPCR 2025 | 4D-ACS Study: One-Month Dual Antiplatelet Therapy Followed by Low-Dose Prasugrel Monotherapy

While dual antiplatelet therapy (DAPT) has long been the standard treatment for managing patients with acute coronary...
Dr. Andrés Rodríguez -
Structural heart disease

One-Year Mortality Trends Following TAVR: STS/ACC TVT Registry Outcomes

Transcatheter aortic valve replacement (TAVR) has quickly consolidated as a safe and effective treatment option for patients...
Dr. Andrés Rodríguez -